Facilitated By

San Antonio Medical Foundation

A LONG TERM FOLLOW-UP REGISTRY FOR ADOLESCENT AND PEDIATRIC SUBJECTS WHO RECEIVED A GILEAD HEPATITIS C VIRUS DIRECT ACTING ANTIVIRAL (DAA) IN GILEAD-SPONSORED CHRONIC HEPATITIS C INFECTION TRIALS

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Mittal, Naveen K
Funded by
TEXAS LIVER INSTITUTE
Research Start Date
Status
Active
Collaborative Project
Clinical Care
Drug Discovery
Other